Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Astragalus for Symptomatic Alleviation in Patients With High-grade Lymphoma Treated With Chemotherapy: a Double-blind Randomized Placebo-controlled Trial

NCT06510530 is registered in ClinicalTrials.gov with Bnai Zion Medical Center as lead sponsor.

NCT NCT06510530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06510530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Astragalus for Symptomatic Alleviation in Patients With High-grade Lymphoma Treated With Chemotherapy: a Double-blind Randomized Placebo-controlled Trial
Lead sponsor
Bnai Zion Medical Center
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 31, 2027
Completion date
August 31, 2032
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade lymphoma